课题基金 / 基金详情

ROSWELL PARK CANCER INSTITUTE CENTER SUPPORT GRANT

ROSWELL PARK CANCER INSTITUTE CENTER SUPPORT GRANT
罗斯威尔公园癌症研究所中心支持补助金
批准号:
2700312
负责人:
YOUCEF M RUSTUM
金额:
$212.85万
依托单位国家:
美国
项目类别:
财政年份:
1983
资助国家:
美国
项目状态:
已结题
起止时间:
1983-12-01 至 2000-04-30

项目摘要

项目成果

YOUCEF M RUSTUM的其他基金

相关文献

中文摘要
翻译
这是针对癌症中心支持的竞争性续订申请 罗斯威尔公园癌症研究所(RPCI)的格兰特。NCI指定的 综合癌症中心,资助期间为1985-2000年。在.之下 研究所主席兼首席执行官托马斯·B·托马西,医学博士,博士 这笔赠款正在进入其不间断资助的第20个年头。超过了 在过去的二十年里,CCSG为 RPCI的研究计划。目前的CCSG应用程序反映了 RPCIS研究方案的重大演变和进展 包括6个成熟方案、2个发展中方案和12个共享方案 资源,其中七个是新的或显著扩大的资源 学院核心助学金与恩惠基金合并后的延续 癌症药物中心核心拨款。 自上次CCSG续签以来,RPCI发生了许多变化 研究计划,包括招聘新的高级教员,科学 和临床科室进行了重组,主要的资本投资 纽约州承诺设计和建造一项新的研究 实验室、隔室、护理塔、门诊和诊疗中心 处理设施,除了对现有设施进行重大翻新外 研究设施。CCSG在规划和实施过程中发挥核心作用 罗斯韦尔的基础和临床评估、支持和管理 研究项目。随着本CCSG的续签,结合 纽约州承诺支持罗斯威尔公园的癌症使命 及其高度敬业的研究人员,罗斯威尔公园将准备好 进入下个世纪,美国将成为领先的癌症中心之一。
英文摘要
This is a competitive renewal application for the Cancer Center Support Grant of Roswell Park Cancer Institute (RPCI). an NCI-designated Comprehensive Cancer Center, for the grant period 1985 - 2000. Under the leadership of Institute President and CEO, Thomas B. Tomasi, M.D., Ph.D, this grant is entering its 20th year of uninterrupted funding. Over the past two decades, the CCSG has provided indispensable support to the research programs of RPCI. The present CCSG application reflects the significant evolution and progress of RPCIs research programs with the inclusion of 6 mature programs, 2 developing programs and 12 shared resources, seven of which are new or significantly expanded resources carried over from the merger of the Institute Core Grant with the Grace Cancer Drug Center Core Grant. Since the last CCSG renewal, there have been numerous changes in the RPCI research programs including recruitment of new senior faculty, scientific and clinical departments have been reorganized, major capital investments and the commitment of New York State to design and build a new research laboratory, vivarium, nursing tower, ambulatory clinic and diagnostic and treatment facility, all in addition to major renovations to existing research facilities. The CCSG plays a central role in the planning and evaluation, support and administration of Roswell's basic and clinical research programs. With the renewal of this CCSG, combined with the commitment of New York State to support the cancer mission of Roswell Park and its highly dedicated research faculty, Roswell Park will be poised to enter the next century as one of the nations leading cancer centers.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
IMPROVING ANIMAL RESOURCES FOR CANCER RESEARCH AT RPCI
Irinotecan in Combination with Celecoxib: A phase I Stu*
ROSWELL PARK DNA REPLICATION PROG FACIL: ANTITUMOR DRUG
ROSWELL PARK DNA REPLICATION PROG FACIL: GENET SMOKING